Cargando…
Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
SIMPLE SUMMARY: Early diagnosis of ovarian cancer is challenging due to vague symptoms and a lack of screening tools. We aimed to evaluate two simple, non-invasive urine biomarkers, CA125 and HE4, for the diagnosis of ovarian cancer in symptomatic women. Paired urine and serum samples were collected...
Autores principales: | Barr, Chloe E., Njoku, Kelechi, Owens, Gemma L., Crosbie, Emma J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953976/ https://www.ncbi.nlm.nih.gov/pubmed/36831601 http://dx.doi.org/10.3390/cancers15041256 |
Ejemplares similares
-
Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2022) -
Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features
por: Barr, Chloe E., et al.
Publicado: (2022) -
Urinary biomarkers for the detection of ovarian cancer: a systematic review
por: Owens, Gemma L, et al.
Publicado: (2022) -
The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
por: Barr, Chloe E., et al.
Publicado: (2022) -
HE4, CA-125, and cystic ovarian mass
por: Wiwanitkit, Viroj
Publicado: (2012)